Immuron CEO Steven Lydeamore to present at Peak Sky High : v

MELBOURNE, Australia, May 31, 2024 -- Immuron Limited , an Australian based and globally integrated biopharmaceutical company, is pleased to advise our Chief Executive Officer Steven Lydeamore will...

Related Keywords

Canada , Australia , Melbourne , Victoria , United States , American , Australian , Flagellin Sears , Steven Lydeamore , Immuron Platform Technology , Immuron Limited , Securities Exchange , Nasdaq , Chief Executive Officer Steven Lydeamore , Peak Asset Management , Peak Sky High , Australian Register , Therapeutic Goods , Traveler Diarrhea , Opin Infect , Scandinavian Journal , Tropical Medicine , Immune Components , Anti Diarrheagenic Enterotoxigenic Escherichia , Hyperimmune Bovine Colostrum , Immuron News , Securities Act , Securities Exchange Act ,